Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
暂无分享,去创建一个
J. Bresee | H. Maltezou | K. Moore | P. Lambach | M. McCarron | Amanda Bolster | Alison Kraigsley | D. Richardson | Maya Peters | Meredith Arpey | Michelle Sonnenberger
[1] L. Menning,et al. The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers’ recommendation of influenza vaccine in pregnancy , 2020, Vaccine.
[2] M. Jit,et al. Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness. , 2020, Vaccine.
[3] P. Hotez,et al. Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles. , 2020, Current opinion in virology.
[4] T. Cherian,et al. Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16–17, Berlin, Germany , 2019, Vaccine.
[5] M. Lwin,et al. Acceptance and uptake of influenza vaccines in Asia: A systematic review. , 2019, Vaccine.
[6] Phillip M. Muthoka,et al. The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships , 2019, Vaccine.
[7] M. McMorrow,et al. Health and economic burden of influenza‐associated illness in South Africa, 2013‐2015 , 2019, Influenza and other respiratory viruses.
[8] J. Bresee,et al. Progress and Remaining Gaps in Estimating the Global Disease Burden of Influenza , 2018, Emerging infectious diseases.
[9] N. MacDonald,et al. Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017 , 2018, Vaccine.
[10] J. Bresee,et al. Advances in measuring influenza burden of disease , 2018, Influenza and other respiratory viruses.
[11] M. Monze,et al. The national burden of influenza‐associated severe acute respiratory illness hospitalization in Zambia, 2011‐2014 , 2017, Influenza and other respiratory viruses.
[12] O. Anzala,et al. National burden of hospitalized and non‐hospitalized influenza‐associated severe acute respiratory illness in Kenya, 2012‐2014 , 2017, Influenza and other respiratory viruses.
[13] Jan Kyncl,et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.
[14] N. K. Susilarini,et al. Estimated incidence of influenza‐associated severe acute respiratory infections in Indonesia, 2013‐2016 , 2017, Influenza and other respiratory viruses.
[15] Mahmudur Rahman,et al. Estimates of seasonal influenza‐associated mortality in Bangladesh, 2010‐2012 , 2017, Influenza and other respiratory viruses.
[16] C. Granados,et al. The national burden of influenza‐associated severe acute respiratory illness hospitalization in Rwanda, 2012‐2014 , 2017, Influenza and other respiratory viruses.
[17] Sera Thomas,et al. Risk factors for serious outcomes associated with influenza illness in high‐ versus low‐ and middle‐income countries: Systematic literature review and meta‐analysis , 2017, Influenza and other respiratory viruses.
[18] R. Hutubessy,et al. Rationale and opportunities in estimating the economic burden of seasonal influenza across countries using a standardized WHO tool and manual , 2017, Influenza and other respiratory viruses.
[19] J. Hombach,et al. A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization , 2016, Vaccine.
[20] M. C. Danovaro-Holliday,et al. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic , 2016, Human vaccines & immunotherapeutics.
[21] E. Azziz-Baumgartner,et al. Estimating the burden of influenza‐associated hospitalizations and deaths in Central America , 2016, Influenza and other respiratory viruses.
[22] A. Mamun,et al. Economic burden of influenza-associated hospitalizations and outpatient visits in Bangladesh during 2010 , 2014, Influenza and other respiratory viruses.
[23] Heidi J Larson,et al. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. , 2014, Vaccine.
[24] M. Jit,et al. Influenza vaccines in low and middle income countries , 2013, Human vaccines & immunotherapeutics.
[25] M. Widdowson,et al. Influenza in Africa: uncovering the epidemiology of a long-overlooked disease. , 2012, The Journal of infectious diseases.
[26] M. Kieny,et al. 2009 Pandemic influenza A virus subtype H1N1 vaccination in Africa--successes and challenges. , 2012, The Journal of infectious diseases.
[27] A. Ciapponi,et al. Burden of influenza in Latin America and the Caribbean: a systematic review and meta‐analysis , 2012, Influenza and other respiratory viruses.
[28] P. Horby,et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. , 2012, The Lancet. Infectious diseases.
[29] M. C. Danovaro-Holliday,et al. Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean. , 2012, Vaccine.
[30] Harish Nair,et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis , 2011, The Lancet.
[31] M. Kieny,et al. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer. , 2011, Vaccine.
[32] Mark A. Miller,et al. Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] Alexander W. Cappelen,et al. Demand for Childhood Vaccination – Insights from Behavioral Economics , 2010 .
[34] Brian Chin,et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis , 2006, The Lancet.
[35] S. Jamieson. Likert scales: how to (ab)use them , 2004, Medical education.
[36] Jacqueline Murray. Likert Data: What to Use, Parametric or Non-Parametric? , 2013 .